Acute changes in the retina and central retinal artery with methamphetamine

Area of Science:

• Ophthalmology
• Neuroscience
• Toxicology

Background:

• Methamphetamine (METH) is a stimulant drug linked to cardiovascular and neurological issues.
• Ophthalmic complications from METH use are known but poorly understood.

Purpose of the Study:

• To investigate the specific effects of METH on retinal structure and function.
• To elucidate the molecular mechanisms underlying METH-induced retinal damage.

Main Methods:

• Mice received escalating METH doses over 5 days.
• Evaluated retinal morphology, cell death (TUNEL assay), and astrocyte activation (GFAP).
• Measured norepinephrine, tumor necrosis factor-α, PECAM-1, syndecan-1, glypican-1, and matrix metalloproteinases (MMPs).

Main Results:

• METH reduced retinal thickness and nuclear counts, increased cell death and astrocyte activation.
• Elevated plasma norepinephrine and retinal tumor necrosis factor-α were observed.
• Decreased Platelet endothelial cell adhesion molecule-1 (PECAM-1) and endothelial proteoglycans, alongside increased MMPs in retina and plasma.

Conclusions:

• METH induces retinal degeneration.
• Damage involves vascular loss of PECAM-1 and the glycocalyx.
• Increased MMPs contribute to METH-induced retinal pathology.